Extensive and partial protein hydrolysate preterm formulas: the effect on growth rate, protein metabolism indices,

H Szajewska1, P Albrecht, B Stoitiska

  • 1Department of Paediatric Gastroenterology & Nutrition, The Medical University of Warsaw, Poland. hania@ipgate.pl

Insights

Extensive (EH) and partial (PH) protein hydrolysate preterm formulas showed nutritional equivalence to standard preterm formulas (SF). Infants fed EH and PH exhibited improved weight gain and protein metabolism markers compared to those receiving fortified breast milk (FBM).

Area of Science:

  • Neonatal Nutrition
  • Pediatric Gastroenterology
  • Biochemistry

Background:

  • Nutritional adequacy data for protein hydrolysate preterm formulas is limited, restricting their use.
  • This study addresses the scarcity of data by evaluating growth and protein metabolism in infants fed specialized formulas.

Purpose of the Study:

  • To assess the nutritional adequacy of extensive (EH) and partial (PH) protein hydrolysate preterm formulas.
  • To compare growth rates and protein metabolism indices in low-birth weight infants fed EH, PH, standard preterm formula (SF), or fortified breast milk (FBM).

Main Methods:

  • A randomized controlled trial involving 61 low-birth weight infants.
  • Infants were assigned to receive EH, PH, SF, or FBM for 12 weeks.
  • Growth parameters and biochemical markers were measured at baseline and at 4, 8, and 12 weeks.

Main Results:

  • No significant differences in growth rates or most protein metabolism markers were observed between EH, PH, and SF groups.
  • Infants fed EH and PH showed significantly higher weight gain, serum urea, and plasma essential amino acids compared to FBM.
  • Specific amino acid differences (valine, tyrosine) were noted between hydrolyzed formulas and FBM.

Conclusions:

  • Experimental extensive and partial protein hydrolysate preterm formulas are nutritionally equivalent to standard preterm formulas.
  • These hydrolyzed formulas may offer advantages in growth and protein metabolism compared to fortified breast milk in specific contexts.
Abstract

Related Concept Videos

Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Proteins: Dietary Sources and Requirements01:28

Proteins: Dietary Sources and Requirements

Consuming animal-based products offers high-quality proteins that contain optimal levels and combinations of essential amino acids, crucial for tissue repair and growth. Foods like eggs, milk, fish, and most meats are a source of complete proteins. Legumes and cereals are abundant in proteins; however, they typically lack a full range of essential amino acids. As a result, they are considered incomplete protein sources. Some plant sources like soybeans, quinoa, and amaranth do contain complete...
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...